IL6 and stroke disorder: Our study demonstrated that Tongxinluo, as an adjunctive therapy, significantly improved overall efficacy, NIHSS score, TC, hs-CRP, LDL, HDL, TNF-α, IL-6, high-shear whole blood viscosity, low-shear whole blood viscosity, Barthel index score, plaque area, MMSE score, FM score, plasma viscosity, plasma fibrinogen, red blood cell volume, NO, and quality of life index in stroke patients.